Comparison of Amantadine and Desipramine Combined with Psychotherapy for Treatment of Cocaine Dependence

References

• Adams E. H., Gfroerer J. C., Rouse B. A. Trends in prevalence and consequence of cocaine use. Adv Alcohol Substance Abuse 1986; 6: 49–71
   PubMedGoogle Scholar
• Colliver J. A decade of DAWN: Cocaine related cases, 1976–1985, Division of Epidemiological and Statistical Publication. National Institute on Drug Abuse, Washington, D.C. 1987
   Google Scholar
• Division of Epidemiological and Statistical Publication. National Institute on Drug Abuse, Cocaine client admissions 1976–1985 [DHHS Publication (ADM) 87–1528]. Government Printing Office, Washington, D.C. 1987
   Google Scholar
• Gawin F. H., Kleber H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: Clinical observations. Arch. Gen. Psychiatry 1986; 43: 107–113
   PubMed Web of Science ®Google Scholar
• Gawin F. H., Ellinwood E. H., Jr. Cocaine and other stimulants: Actions, abuse and treatment. N. Engl. J. Med. 1988; 318: 1173–1182
   PubMed Web of Science ®Google Scholar
• Goeders N. E., Smith J. E. Cortical dopaminergic involvement in cocaine reinforcement. Science 1983; 221: 773–775
   PubMed Web of Science ®Google Scholar
• Wise R. A. Neural mechanisms of the reinforcing action of cocaine. Natl. Inst. Drug Abuse Res. Monogr. Ser. 1985; 50: 15–33
   Google Scholar
• Kokkinidis L., Zacharko R. Response sensitization and depression following long-term amphetamine treatment in a self-stimulation pradigm. Psychopharmacology 1980; 68: 73–76
   PubMedGoogle Scholar
• Leith N. J., Barrett R. J. Self-stimulation and amphetamine: Tolerance to d and / isomers and cross tolerance to cocaine and methylphenidate. Psychopharmacology 1981; 74: 23–28
   PubMed Web of Science ®Google Scholar
• Wagner G. C., Seiden L. S., Schuster C. R. Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs. Drug Alcohol Depend 1979; 4: 435–438
   PubMed Web of Science ®Google Scholar
• Moore K. E., Chiueh C. C., Zeldes G. Release of neurotransmitters from the brain in vivo by amphetamine, methylphenidate, and cocaine. Cocaine and Other Stimulants, E. H. Ellinwood, M. M. Kilbey. Plenum, New York 1977; 143–160
   Google Scholar
• Goeders N. E., Smith J. E. Cortical dopaminergic involvement in cocaine reinforcement. Science 1983; 22(1)773–775
   Google Scholar
• Dackis C. A., Gold M. S. New concepts in cocaine addiction: The dopamine depletion hypothesis. Neurosci. Biobehav. Rev. 1985; 9: 1–9
   Google Scholar
• Banerjee S. P., Sharman V. K., Kung-Cheung L. S. Cocaine and d-amphetamine induce changes in central β-adrenoceptor sensitivity: Effects of acute and chronic drug treatment. Brain Res. 1979; 175: 119–130
   PubMedGoogle Scholar
• Taylor D. L., Ho B. T., Fagan J. D. Increased dopamine receptor binding in rat brain by repeated cocaine injections. Commun. Psychopharmacol. 1979; 3: 137–142
   PubMedGoogle Scholar
• Kleber H. D., Gawin F. H. The physiology of cocaine craving and “crashing,”. Arch. Gen. Psychiatry 1987; 44: 299–300
   Google Scholar
• Gawin F. H., Kleber H. D. Cocaine abuse treatment: Open pilot trial with desipramine and lithium carbonte. Arch. Gen. Psychiatry 1984; 42: 903–910
   Google Scholar
• Kosten T. R., Schuman B., Wright D. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. J. Clin. Psychiatry 1987; 442–444
   PubMedGoogle Scholar
• Tennant F. S., Tarver A. L. Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence. Natl. Inst. Drug Abuse Res. Monogr. Ser. 1983; 43: 351–355
   Google Scholar
• Tennant F. S., Tarver A. L. Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence. Nail. Inst. Drug Abuse Res. Monogr. Ser. 1984; 55: 159–163
   PubMedGoogle Scholar
• Giannini A. J., Malone D. A., Giannini M. C. Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine. J. Clin. Pharmacol. 1986; 26: 211–214
   PubMed Web of Science ®Google Scholar
• Giannini A. J., Billett W. Bromocriptine-desipramine protocol in treatment of cocaine addiction. J. Clin. Pharmacol. 1987; 27: 549–554
   PubMed Web of Science ®Google Scholar
• Gawin F. H., Kleber H. D. Desipramine Facilitation of Cocaine Abstinence. Presented at the American Psychiatric Association 141st Annual Meeting, Montreal, QuebecCanada, May 11, 1988
   Google Scholar
• Tennant F. S., Jr., Sagherian A. A. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch. Intern. Med. 1987; 1147: 109–112
   Google Scholar
• Handelsman L., Quesada T. P., Chordia P. L. Amantadine Treatment of Cocaine Abuse. Presented at the 140th Convention of the American Psychiatric Convention, Chicago, Illinois, May 11, 1987
   Google Scholar
• Gawin F. H. New uses of antidepressants in cocaine abuse. Psychosomatics 1986; 27: S24–S29
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. American Psychiatric Association Press, Washington, D.C. 1987
   Google Scholar
• Weddington W. W., Brown B. S. Acceptance of HTV-antibody testing by persons seeking outpatient treatment for cocaine abuse. J. Substance Abuse Treatment 1988; 5: 145–149
   PubMed Web of Science ®Google Scholar
• Rounsaville B. J., Gawin F. H., Kleber H. D. Interpersonal psychotherapy adapted for ambulatory cocaine abusers. Am. J. Drug Alcohol Abuse 1985; 11: 171–191
   PubMed Web of Science ®Google Scholar
• Endicott J., Spitzer R. L. A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch. Gen, Psychiatry 1978; 37: 837–844
   Google Scholar
• Spitzer R. L., Endicott J., Robins E. Research diagnostic criteria: Rationale and reliability. Arch. Gen. Psychiatry 1978; 35: 773–789
   PubMed Web of Science ®Google Scholar
• Derogatis L. R., Lipman R. S., Covi L. The SCL-90: An outpatient psychiatric rating scale. Psychopharmacol. Bull. 1973; 9: 13–28
   PubMedGoogle Scholar
• Shipley W. C. Shipley Institute of Living Scale. Western Psychological Services, Los Angeles, California 1984
   Google Scholar
• Wender P. H., Reimherr F. W., Wood D. R. Attention deficit disorder (“minimal brain dysfunction”) in adults. Arch. Gen. Psychiatry 1981; 38: 449–456
   PubMed Web of Science ®Google Scholar
• Beck A. T., Ward C. H., Mendelson M. An interview for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561–571
   PubMed Web of Science ®Google Scholar
• Plumb M. M., Holland J. Comparative studies of psychological function in patients with advanced cancer. I. Self-reported depressive symptoms. Psychosom. Med. 1977; 39: 264–276
   PubMed Web of Science ®Google Scholar
• Council on Scientific Affairs. Scientific issues in drug testing. J. Am. Med. Assoc. 1987; 257: 3110–3114
   PubMed Web of Science ®Google Scholar
• Overall J. E., Biggs J., Jacobs M. Comparison of alprazolam and imipramine for treatment of outpatient depression. J. Clin. Psychiatry 1987; 48: 15–19
   PubMedGoogle Scholar
• Nelson J. C., Jatlow P., Quinlan D. M. Desipramine plasma concentration and antidepressant response. Arch. Gen. Psychiatry 1982; 39: 1419–1422
   PubMed Web of Science ®Google Scholar
• Aoki F. Y., Stiver H. G., Sitar D. S. Prophylactic amantadine dose and plasma concentration-effect relationship in healthy adults. Clin. Pharmacol. Ther. 1985; 37: 128–136
   PubMedGoogle Scholar
• Aoki F. Y., Sitar D. S. Clinical pharmacokinetics of amantadine hydrochloride. Clin. Pharmacokinet. 1988; 14: 35–51
   PubMed Web of Science ®Google Scholar
• Ball J. C. The reliability and validity of interview data obtained from 59 narcotic drug addicts. Am. J. Sociol. 1967; 72: 650–654
   PubMed Web of Science ®Google Scholar
• Amsel A., Mandell W., Matthias L. Reliability and validity of self-reported illegal activities and drug use collected from narcotic addicts. Int. J. Addict. 1976; 11: 325–336
   PubMed Web of Science ®Google Scholar